Calcitonin-Salmon

Miacalcic

密鈣息注射液

100IU/ml/amp

11. ENDOCRINE AND METABOLIC; ;

11.21. CALCITONIN-SALMON;;

Treatment of Paget’s disease of bone (osteitis deformans), adjunctive therapy for hypercalcemia, postmenopausal osteoporosis and osteogenesis imperfecta

高血鈣危象、骨骼的帕哲特氏症(僅適合對替代療法無效或不適合這類療法的病人，如腎功能嚴重受損者)

C 動物試驗顯示有致畸胎的結果，但沒有針對孕婦或動物有對照組的研究可證明其危險性。

Unknown

IM, SC, IVP/IVD
Paget’s disease
Adults: 100IU/day to start, 50IU/day or 50-100IU every 1-3 days as maintenance dose
Hypercalcemia
Adults: initial 4IU/kg q12h; increase up to 8IU/kg q12h to a maximum of q6h
Osteogenesis imperfecta
Adults: 2IU/kg 3 times/wk
Postmenopausal osteoporosis
IM, SC: 100IU/day

Facial flushing, nausea, diarrhea, anorexia, edema at injection site, polyuria, back or joint pain, nasal bleeding/crusting, dyspnea

Hypersensitivity to salmon protein or gelatin diluent

1. Administration of calcitonin possibly could lead to hypocalcemic tetany, in relapse of Paget's disease, a dosage increase beyond 100IU/day does not improve response.
2.需冷藏。
3.若注射量超過2ml適用肌肉注射，並在不同部位施打

建立者

100224

建立時間

維護者

103617

維護時間

2022-11-17 14:31:03